Avid Bioservices Inc (CDMO)

[entdoc]

Vinmantu, I was not hedging, but leaving open the small (small to the vanishing point) chance that Bavi could be used in combo with other immunology-oncology agents for advanced lung cancer. As usual (and as said before), the people who really understand what is going on are those who have the postmortem target tumor on a slide, stained appropriately, under a microscope. That tells a story that theorizing on the number of -PS receptor sites left open after Bavi dosing will not tell. Cheers!